JUAN BRUBAKER: Open Payments
NPI 1598430548 · BURLESON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$376 in 21 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $376
Food & beverage: $376
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $73 |
| Novo Nordisk Inc | 4 | $65 |
| ABBVIE INC. | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Biogen, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $16 |
Products named: MOUNJARO, VRAYLAR, Ozempic, ZURZUVAE, PREVNAR 20, TRELEGY ELLIPTA, UBRELVY, FREESTYLE LIBRE.
Industry payments across TX — which companies pay providers there.
